StockIQ.techAbbott Laboratories (ABT) Stock Analysis
Free AI-powered analysis and research for Abbott Laboratories stock
Sector: Healthcare
ABT snapshot
Data as of 4 Nov 2026 close. Updated daily.
Abbott Laboratories scores 58/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 66% of its 52-week range, down 8.4% over the past year. Latest reported figures show a profit margin of 9.7% and revenue growth of +14.5%.
What is driving the score
- Uptrend: +7
- MACD Bullish: +8
- High P/E (38.8): -10
- Strong Long-term Uptrend: +8
- Underperforming (-8.4% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ABT report
Abbott Laboratories (ABT) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ABT Now →📰 Latest Update
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
Tue, October 27, 2026 at 12:30 PM UTC 4 min read
Abbott Laboratories (ABT) has garnered positive attention from Wall Street analysts, who express optimism about the company's growth prospects. This bullish sentiment is significant for investors as it may indicate potential stock price appreciation and strong future performance, driven by Abbott's diverse product portfolio and ongoing innovations in healthcare. As analysts recommend ABT as a buy, investors may want to consider the stock for potential long-term gains.